Table 1
Patient Characteristics
Event-Positive Patients (n=11)
Event-Negative Patients (n=15)
Mean, No. (%)
±SD 9.38
Mean, No. (%)
±SD 9.69
P-value
Age
57.64
60.67
0.43 0.43
Male sex
5/11 (45%)
10/15 (66%)
Underlying comorbidities
Hypertension
7/11 (64%) 5/11 (45%) 1/11 (9%)
10/15 (67%) 7/15 (47%) 3/15 (20%) 1/15 (7%) 4/15 (27%) 7/15 (47%) 5/15 (33%) 12/15 (80%) 13/15 (87%) 13/15 (87%) 14/15 (93%) 13/15 (87%) 4/15 (27%) 14/15 (93%)
1 1
Diabetes Mellitus
Coronary artery disease Congestive Heart Failure Chronic Kidney Disease
0.61
0/11 0/11
1
0.11
Predominant presenting symptoms Hypoxemia and/or SOB
7/11 (64%) 8/11 (73%) 9/11 (82%) 7/11 (64%)
0.45 0.11
Fever
Mechanical Ventilation Dexmedetomidine Hydroxychloroquine
1
0.35 0.49
11/11 (100%) 10/11 (91%) 11/11 (100%)
Azithromycin Anticoagulation
1
0.49 0.68
AV-nodal blockers and AADs Qualitative Troponin I assessment
4/11 (36%) 9/11 (82%)
1
Peak Troponin I, ng/mL
2.72 7703 23.98
4.48
0.42 1905 20.24
0.52 2422 11.52
0.07 0.16 0.38 0.85 0.29 0.84 0.51 0.82
NT-ProBNP, pg/mL
12995
Peak C-reactive protein, mg/dL
9.07
D-dimer, ng/mL
4128.91
1609.63 112.84
3996.36
1756.95
Peak Procalcitonin, ng/mL
42.15 83.45
10.31 84.62
15.87 16.82 29.23 36.12
QRS duration (ms) PR Interval (ms) QTc interval (ms)
8.86
148.55
21.37
155.69 462.69
458
59.6
Deceased 0.78 Abbreviations: SD, standard deviation; AV, atrioventricular; AAD, antiarrhythmic drugs; NT-ProBNP, N-terminal-proB-type natriuretic peptide SI conversion factors: To convert Troponin I to µg/L, multiply by 1; NT-ProBNP to pmol/L, multiply by 0.1182; C-reactive protein to mg/L, multiply by 10; D-dimer to µg/L, multiply by 1; Procalcitonin to ng/L, multiply by 1000. 5/11 (45%) 6/15 (40%)
Made with FlippingBook Digital Publishing Software